Peter van Balen

856 total citations
35 papers, 518 citations indexed

About

Peter van Balen is a scholar working on Immunology, Hematology and Epidemiology. According to data from OpenAlex, Peter van Balen has authored 35 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 18 papers in Hematology and 7 papers in Epidemiology. Recurrent topics in Peter van Balen's work include T-cell and B-cell Immunology (16 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Immunotherapy and Immune Responses (11 papers). Peter van Balen is often cited by papers focused on T-cell and B-cell Immunology (16 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Immunotherapy and Immune Responses (11 papers). Peter van Balen collaborates with scholars based in Netherlands, Germany and United States. Peter van Balen's co-authors include J.H. Frederik Falkenburg, Inge Jedema, Michel G.D. Kester, Constantijn J.M. Halkes, Marieke Griffioen, Cor J. Kalkman, Gert W. van Dijk, Olaf L. Cremer, Karel G.M. Moons and Hendrik Veelken and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The EMBO Journal.

In The Last Decade

Peter van Balen

32 papers receiving 502 citations

Peers

Peter van Balen
Tomasz Rozmysłowicz United States
Ann Van de Velde Belgium
F. T. Cordingley United Kingdom
R Brown United States
Takahisa� Nakanishi Japan
Femke Stephan Netherlands
David Bloxham United Kingdom
Sandra Grässle Germany
Linda Berberian United States
Kun Soo Lee South Korea
Tomasz Rozmysłowicz United States
Peter van Balen
Citations per year, relative to Peter van Balen Peter van Balen (= 1×) peers Tomasz Rozmysłowicz

Countries citing papers authored by Peter van Balen

Since Specialization
Citations

This map shows the geographic impact of Peter van Balen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter van Balen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter van Balen more than expected).

Fields of papers citing papers by Peter van Balen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter van Balen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter van Balen. The network helps show where Peter van Balen may publish in the future.

Co-authorship network of co-authors of Peter van Balen

This figure shows the co-authorship network connecting the top 25 collaborators of Peter van Balen. A scholar is included among the top collaborators of Peter van Balen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter van Balen. Peter van Balen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borne, Peter A. von dem, Peter van Balen, Erik W.A. Marijt, et al.. (2024). Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation. Frontiers in Immunology. 15. 1335341–1335341. 2 indexed citations
2.
Arrieta‐Bolaños, Esteban, Tobias Gedde‐Dahl, Marie Robin, et al.. (2024). Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS. Blood. 144(16). 1747–1751. 4 indexed citations
3.
Roeven, Mieke W.H., Annoek E. C. Broers, Anna van Rhenen, et al.. (2024). Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data. Blood Advances. 8(7). 1683–1686. 2 indexed citations
4.
Meent, Marian van de, M. Willy Honders, Indu Khatri, et al.. (2024). Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens. Blood. 143(18). 1856–1872. 6 indexed citations
5.
Karakaslar, Emin Onur, Elena Sánchez‐López, Peter A. van Veelen, et al.. (2024). A transcriptomic based deconvolution framework for assessing differentiation stages and drug responses of AML. npj Precision Oncology. 8(1). 105–105. 5 indexed citations
6.
Kester, Michel G.D., Marian van de Meent, Rob C. M. de Jong, et al.. (2024). DNA barcoded peptide-MHC multimers to measure and monitor minor histocompatibility antigen-specific T cells after allogeneic stem cell transplantation. Journal for ImmunoTherapy of Cancer. 12(12). e009564–e009564.
7.
Borne, Peter A. von dem, Peter van Balen, Erik W.A. Marijt, et al.. (2023). Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients. Annals of Hematology. 102(5). 1203–1213. 4 indexed citations
8.
Kester, Michel G.D., Lois Hageman, Arnoud H. de Ru, et al.. (2022). Promiscuity of Peptides Presented in HLA-DP Molecules from Different Immunogenicity Groups Is Associated With T-Cell Cross-Reactivity. Frontiers in Immunology. 13. 831822–831822. 10 indexed citations
9.
Crivello, Pietro, Michel G.D. Kester, Dominik A. Megger, et al.. (2020). Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DM. Blood. 137(7). 923–928. 32 indexed citations
10.
Kemps, Paul G., Arjen H.G. Cleven, Tom van Wezel, et al.. (2020). B‐cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement. American Journal of Hematology. 95(11). 1427–1429. 3 indexed citations
11.
Balen, Peter van, Lothar Germeroth, Lois Hageman, et al.. (2019). Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation—a phase I/II study. Leukemia. 34(3). 831–844. 19 indexed citations
12.
Balen, Peter van, Cornelis A.M. van Bergen, Simone A.P. van Luxemburg-Heijs, et al.. (2018). CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II. Frontiers in Immunology. 9. 3016–3016. 27 indexed citations
13.
Balen, Peter van, Alwine B. Kruisselbrink, Károly Szuhai, et al.. (2018). Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction. Frontiers in Immunology. 9. 331–331. 6 indexed citations
14.
15.
Arrieta‐Bolaños, Esteban, Peter van Balen, J.H. Frederik Falkenburg, et al.. (2018). Dissecting Genetic Control of HLA-DPB1 Expression and Its Relation to Structural Mismatch Models in Hematopoietic Stem Cell Transplantation. Frontiers in Immunology. 9. 2236–2236. 19 indexed citations
16.
Arrieta‐Bolaños, Esteban, Pietro Crivello, Julie Rytlewski, et al.. (2018). Alloreactive T Cell Receptor Diversity against Structurally Similar or Dissimilar HLA-DP Antigens Assessed by Deep Sequencing. Frontiers in Immunology. 9. 280–280. 7 indexed citations
17.
Balen, Peter van, Simone A.P. van Luxemburg-Heijs, Marian van de Meent, et al.. (2017). Mismatched HLA-DRB3 Can Induce a Potent Immune Response After HLA 10/10 Matched Stem Cell Transplantation. Transplantation. 101(12). 2850–2854. 6 indexed citations
18.
Tick, Lidwine W., Carine J.M. Doggen, Frits R. Rosendaal, et al.. (2010). Predictors of the post‐thrombotic syndrome with non‐invasive venous examinations in patients 6 weeks after a first episode of deep vein thrombosis. Journal of Thrombosis and Haemostasis. 8(12). 2685–2692. 58 indexed citations
19.
Balen, Peter van, et al.. (2009). A Dutch Family with Hb Debrousse: Severe Anemia After Parvovirus B19 Infection. Hemoglobin. 33(3-4). 269–273.
20.
Sonnenberg, Arnoud, Peter van Balen, J. Hilgers, Ed Schuuring, & Roel Nusse. (1987). Oncogene expression during progression of mouse mammary tumor cells; activity of a proviral enhancer and the resulting expression of int-2 is influenced by the state of differentiation.. The EMBO Journal. 6(1). 121–125. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomasz Rozmysłowicz Breakdown of academic impact, for papers by Ann Van de Velde Breakdown of academic impact, for papers by F. T. Cordingley Breakdown of academic impact, for papers by R Brown Breakdown of academic impact, for papers by Takahisa� Nakanishi Breakdown of academic impact, for papers by Femke Stephan Breakdown of academic impact, for papers by David Bloxham Breakdown of academic impact, for papers by Sandra Grässle Breakdown of academic impact, for papers by Linda Berberian Breakdown of academic impact, for papers by Kun Soo Lee
Rankless by CCL
2026